Marijuana Firm Cresco Labs Expands In Arizona, Illinois

Just weeks after closing a $100 million capital raise, Chicago-based Cresco Labs is growing again – this time through acquisitions in Arizona and Illinois.

The multistate cannabis firm announced that it has acquired Arizona Facilities Supply, which provides management services to Encanto Green Cross Dispensary. Encanto is licensed to cultivate, process and dispense medical marijuana across the state.

The deal adds two cultivation sites, a processing facility and a dispensary to Cresco’s Arizona portfolio, which already includes a cultivation and dispensary operation.

Terms of the deal, which included cash and equity considerations, were not disclosed.

Cresco also signed a definitive agreement to acquire FloraMedex, a medical cannabis dispensary located in the Chicago suburb of Elmwood Park – Cresco’s third acquisition in Illinois.

Cresco Labs also has operations in California, Nevada, Ohio and Pennsylvania.

“Our growth strategy from Day One has been set on having a national footprint,” Cresco CEO and co-founder Charlie Bachtell said.

“With the pending (merger and acquisition) activity we have in the pipeline, we’re on track to enter a majority of the larger states that we’re not in yet.”

The firm has a license pending in Michigan and is targeting additional acquisitions in New York and Florida.

Lisa Bernard-Kuhn can be reached at [email protected]

Original Article Source: https://mjbizdaily.com/cannabis-firm-cresco-labs-expands-in-arizona-illinois/

Comments

Feds Hire Hazmat Firm For Marijuana Eradication Training

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the substa...

FDA Warns 15 Companies For Illegally Selling CBD Products

The agency also released a consumer update about CBD , the non-psychoactive ingredient in marijuana increasingly used to treat pain and anxiety. Until it learns more about the effectiveness and safety of CBD, the FDA said it cannot generally recognize the ingredient as safe or approve products that contain it. “We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,‘” FDA Principal Deputy Commissioner Amy Abernethy said. The FDA sent letters to the following 15 companies for selling CBD products that violate the Food, Drug and Cosmetic Act, for marketing the products to treat illnesses or for therapeutic use, claiming it’s a dietary supplement or adding it to food for humans and animals. -Red Pill Medical Inc. of Phoenix, Arizona -Pink Collections Inc. of Beverly Hills, California -Healthy Hemp Strategies LLC (does ...

New York Governor Will Visit Legal Marijuana States To Take Lessons Back Home

One week after bills to decriminalize marijuana in Virginia were passed by both the House and Senate , they advanced again on Wednesday in committee votes, where they were revised in an effort to ease the path to the governor’s desk. The goal was to make the language of the bills identical, with lawmakers hoping to streamline the process by avoiding sending differing pieces of decriminalization legislation to a bicameral conference committee to resolve differences. The House of Delegates and Senate were under pressure to approve their respective versions of decriminalization ahead of a crossover deadline last week. After clearing floor votes in their respective chambers, the Senate-passed bill was sent to the House Court of Justice Committee, while the House’s legislation was referred to the Senate Judiciary Committee. Those panels amended the bills and advanced them on Wednesday, with senators voting 10-4 to advance the revised legislation and delegates voting 8-5. However, the Sen...

Norma Pence

Search This Blog